Enhanced COPD Management in Suspected Lung Cancer Patients
Recruiting · NCT07543601 · Interventional (participants receive a specific treatment) · Lead sponsor: Ditte Krag-Hansen
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates. This study aims to assess the impact of early diagnosis and optimal treatment of COPD on clinical outcomes in patients under evaluation for lung cancer. The study will combine information through an open-label RCT at the Lung Cancer Investigation Unit at Lillebaelt Hospital Vejle. The findings could inform clinical practice by emphasizing the importance of integrated care approaches for patients with coexisting COPD and lung cancer, ultimately leading to better health outcomes.
Who can take part
Inclusion criteria
- Undergoing diagnostic evaluation for suspected lung cancer
- Spirometry showing obstructive airflow limitation (FEV₁/FVC \< 75 % or FEV₁ \< 80 %, and no reversibility) at the first outpatient visit at the lung cancer evaluation
Exclusion criteria
- Presence of significant comorbidities that may interfere with diagnostic procedures or spirometry
- Pregnant or breastfeeding women
Where it is running
1 location listed.
- Lung Cancer Investigation Unit, Lillebaelt Hospital Vejle - Vejle, Denmark